Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.

Murphy RT, Mogensen J, McGarry K, Bahl A, Evans A, Osman E, Syrris P, Gorman G, Farrell M, Holton JL, Hanna MG, Hughes S, Elliott PM, Macrae CA, McKenna WJ.

J Am Coll Cardiol. 2005 Mar 15;45(6):922-30.

2.

Glycogen storage diseases presenting as hypertrophic cardiomyopathy.

Arad M, Maron BJ, Gorham JM, Johnson WH Jr, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman CE, Seidman JG.

N Engl J Med. 2005 Jan 27;352(4):362-72.

3.

The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading.

Jørgensen SB, Nielsen JN, Birk JB, Olsen GS, Viollet B, Andreelli F, Schjerling P, Vaulont S, Hardie DG, Hansen BF, Richter EA, Wojtaszewski JF.

Diabetes. 2004 Dec;53(12):3074-81.

4.

The AMP-activated protein kinase pathway--new players upstream and downstream.

Hardie DG.

J Cell Sci. 2004 Nov 1;117(Pt 23):5479-87. Review.

5.

The 5'-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle.

Barnes BR, Marklund S, Steiler TL, Walter M, Hjälm G, Amarger V, Mahlapuu M, Leng Y, Johansson C, Galuska D, Lindgren K, Abrink M, Stapleton D, Zierath JR, Andersson L.

J Biol Chem. 2004 Sep 10;279(37):38441-7. Epub 2004 Jul 6.

6.

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress.

Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, Cantley LC.

Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3329-35. Epub 2004 Feb 25.

7.

CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.

Scott JW, Hawley SA, Green KA, Anis M, Stewart G, Scullion GA, Norman DG, Hardie DG.

J Clin Invest. 2004 Jan;113(2):274-84.

8.

Bateman domains and adenosine derivatives form a binding contract.

Kemp BE.

J Clin Invest. 2004 Jan;113(2):182-4. Review.

9.

Fetal bradycardia at 28 weeks of gestation associated with cardiac glycogen phosphorylase b kinase deficiency.

Bührer C, van Landeghem FK, Felderhoff-Mueser U, Stadelmann C, Obladen M.

Acta Paediatr. 2003 Nov;92(11):1352-3. No abstract available.

PMID:
14696860
10.

LKB1 is the upstream kinase in the AMP-activated protein kinase cascade.

Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D.

Curr Biol. 2003 Nov 11;13(22):2004-8.

11.

Expression profiling of the gamma-subunit isoforms of AMP-activated protein kinase suggests a major role for gamma3 in white skeletal muscle.

Mahlapuu M, Johansson C, Lindgren K, Hjälm G, Barnes BR, Krook A, Zierath JR, Andersson L, Marklund S.

Am J Physiol Endocrinol Metab. 2004 Feb;286(2):E194-200. Epub 2003 Oct 14.

PMID:
14559719
12.

Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis.

Oliveira SM, Ehtisham J, Redwood CS, Ostman-Smith I, Blair EM, Watkins H.

J Mol Cell Cardiol. 2003 Oct;35(10):1251-5.

PMID:
14519435
13.

Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.

Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Mäkelä TP, Alessi DR, Hardie DG.

J Biol. 2003;2(4):28. doi: 10.1186/1475-4924-2-28. Epub 2003 Sep 24.

14.

Continuous subcultivation of epithelial-like cells from normal human tissues.

CHANG RS.

Proc Soc Exp Biol Med. 1954 Nov;87(2):440-3. No abstract available.

PMID:
13237268
15.

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

Hardie DG.

Endocrinology. 2003 Dec;144(12):5179-83. Epub 2003 Sep 4. Review.

PMID:
12960015
16.

Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases.

Burwinkel B, Hu B, Schroers A, Clemens PR, Moses SW, Shin YS, Pongratz D, Vorgerd M, Kilimann MW.

Eur J Hum Genet. 2003 Jul;11(7):516-26.

17.

Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.

Arad M, Moskowitz IP, Patel VV, Ahmad F, Perez-Atayde AR, Sawyer DB, Walter M, Li GH, Burgon PG, Maguire CT, Stapleton D, Schmitt JP, Guo XX, Pizard A, Kupershmidt S, Roden DM, Berul CI, Seidman CE, Seidman JG.

Circulation. 2003 Jun 10;107(22):2850-6. Epub 2003 Jun 2.

18.

Pediatric cardiomyopathy--a long way to go.

Strauss A, Lock JE.

N Engl J Med. 2003 Apr 24;348(17):1703-5. No abstract available.

PMID:
12711746
20.

Clinicopathological features of genetically confirmed Danon disease.

Sugie K, Yamamoto A, Murayama K, Oh SJ, Takahashi M, Mora M, Riggs JE, Colomer J, Iturriaga C, Meloni A, Lamperti C, Saitoh S, Byrne E, DiMauro S, Nonaka I, Hirano M, Nishino I.

Neurology. 2002 Jun 25;58(12):1773-8. Review.

PMID:
12084876

Supplemental Content

Support Center